A large database study suggests that patients with primary dysautonomias face a significantly increased risk for seborrheic ...

It's important to note that itch is the most burdensome symptom of seborrheic dermatitis," says Dr. Woolerry-Lloyd. She also ...

Evommune launches mid-stage trials for immune-modulating drugs targeting skin conditions, backed by $115M funding and led by ...

It is often confused with acne vulgaris, rosacea, and seborrheic dermatitis. The condition's precise etiology remains unknown, though it is often triggered by topical corticosteroids. Oral and ...

As an added bonus, the company claims that according to clinical ... overgrowth. Research suggests selenium sulfide is just as effective as ketoconazole in treating seborrheic dermatitis ...

is being developed as a topical treatment for atopic dermatitis (AD), the most common form of eczema. Zabalafin Hydrogel has demonstrated strong efficacy and safety in Phase 2a clinical trials ...

At all timepoints assessed during the four-week trial ... dermatitis in adult and pediatric patients 6 years of age and older. ZORYVE foam, 0.3%, is indicated for the treatment of seborrheic ...

At all timepoints assessed during the four-week trial, more than ... of mild to moderate atopic dermatitis in adult and pediatric patients 6 years of age and older. ZORYVE foam, 0.3%, is indicated for ...